These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8330513)

  • 41. [Scarlet fever].
    le Lorier B
    Soins; 1979 May; 24(10):17-20. PubMed ID: 380001
    [No Abstract]   [Full Text] [Related]  

  • 42. [Penicillin therapy of scarlet fever].
    Köditz H; Fichtner C; Köhler W
    Kinderarztl Prax; 1974 Jul; 42(7):301-7. PubMed ID: 4444147
    [No Abstract]   [Full Text] [Related]  

  • 43. [The hydrophobicity of Streptococcus pyogenes as a possible marker of its virulence].
    Dmitrieva NF; Briko NI; Vylegzhanina ES; Kondrakova OA; Eshchina AS; Lisitsyna AB; Beliakov VD
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):21-4. PubMed ID: 8701648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Beta-hemolysing streptococci invasion of the pharynx in exanthematic psoriasis].
    Koester H; Fikentscher R
    Dermatol Monatsschr; 1974 Aug; 160(8):650-3. PubMed ID: 4613586
    [No Abstract]   [Full Text] [Related]  

  • 45. [Therapy of scarlet fever].
    Köhler W
    Dtsch Med Wochenschr; 1988 Jan; 113(3):117. PubMed ID: 3338384
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical picture and evolution of scarlet fever due to beta hemolytic group streptococcus].
    Stefanović N; Najdanović Lj; Krajinović S; Nastasović M; Vlajinać H
    Srp Arh Celok Lek; 1978 Sep; 106(9):807-14. PubMed ID: 380014
    [No Abstract]   [Full Text] [Related]  

  • 47. [Yearly epidemiological survey of group A-hemolytic streptococci isolated from throat of healthy children. Part II Analysis by classroom and sibling (author's transl)].
    Nakajima K; Adachi T
    Kansenshogaku Zasshi; 1979 Oct; 53(10):539-46. PubMed ID: 119011
    [No Abstract]   [Full Text] [Related]  

  • 48. A case of varicella complicated by cellulitis and scarlet fever due to Streptococcus pyogenes.
    Oyake S; Ohi T; Koga M
    J Dermatol; 2000 Nov; 27(11):750-2. PubMed ID: 11138545
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Scarlet fever--therapy in practice].
    Harasek G
    Padiatr Padol; 1974; 9(2):189-90. PubMed ID: 4823702
    [No Abstract]   [Full Text] [Related]  

  • 50. Characteristics of Streptococcus pyogenes strains isolated from Chinese children with scarlet fever.
    Liang Y; Shen X; Huang G; Wang C; Shen Y; Yang Y
    Acta Paediatr; 2008 Dec; 97(12):1681-5. PubMed ID: 18691162
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Recurrent scarlet fever due to recent reinfection caused by strains unrelated to Streptococcus pyogenes].
    Sanz JC; Bascones Mde L; Martín F; Sáez-Nieto JA
    Enferm Infecc Microbiol Clin; 2005; 23(6):388-9. PubMed ID: 15970177
    [No Abstract]   [Full Text] [Related]  

  • 52. Bacteriology and urinary examination in impetigo contagiosa. A prospective study in a Swedish urban area.
    Bojs G; Juhlin I; Möller H
    Acta Derm Venereol; 1973; 53(6):481-6. PubMed ID: 4129598
    [No Abstract]   [Full Text] [Related]  

  • 53. [The occurrence of beta-hemolyzing streptococcus A in clinically healthy children and children with laryngitis, scarlet fever and viral pharyngitis as a basis for differential therapeutic considerations].
    Herrmann M; Meyer FP
    Z Gesamte Hyg; 1977; 23(6):412-4. PubMed ID: 331702
    [No Abstract]   [Full Text] [Related]  

  • 54. [On the problem of scarlet fever in rural areas].
    Werthmann K
    Wien Med Wochenschr; 1967 May; 117(20):523-5. PubMed ID: 5586006
    [No Abstract]   [Full Text] [Related]  

  • 55. [Yearly epidemiological survey of group A-hemolytic streptococci isolated from throat of healthy children. Part I Analysis by M type (author's transl)].
    Nakajima K; Adachi T; Hada M
    Kansenshogaku Zasshi; 1979 Oct; 53(10):530-8. PubMed ID: 119010
    [No Abstract]   [Full Text] [Related]  

  • 56. [Penicillin prevention of scarlet fever in nurseries].
    BERNI A; STELLA F
    Nuovi Ann Ig Microbiol; 1958; 9(6):473-84. PubMed ID: 13623091
    [No Abstract]   [Full Text] [Related]  

  • 57. [Treatment of scarlet fever of children with new oral cephalosporin granules (S-640 P or cefatrizine granules) (author's transl)].
    Sato H; Nakazawa S; Chikaoka H; Yamaguchi T
    Jpn J Antibiot; 1976 Feb; 29(2):184-88. PubMed ID: 772247
    [No Abstract]   [Full Text] [Related]  

  • 58. A school-based program for control of group a streptococcal upper respiratory tract infections: a controlled trial in Southern China.
    Lin S; Kaplan EL; Rao X; Johnson DR; Deng M; Zhuo Q; Yang P; Mai J; Dong T; Liu X
    Pediatr Infect Dis J; 2008 Aug; 27(8):753-5. PubMed ID: 18664988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Study of post-streptococcal hypersensitivity by means of the streptolysin O skin test in the framework of complex epidemiologic investigations].
    Mihalcu F; Horhogea G; Debeleac L; Croitorescu M
    Microbiol Parazitol Epidemiol (Bucur); 1970; 15(6):493-504. PubMed ID: 4923760
    [No Abstract]   [Full Text] [Related]  

  • 60. Scarlet fever.
    Nurs Stand; 2014 May; 28(37):20. PubMed ID: 24823566
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.